Who
Patrick F. Williams
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Neuropace; Chief Financial Officer, STAAR Surgical; Director, BioRestorative Therapies; General Manager miraDry & SVP, Sientra; SVP & CFO, Zeltiq Aesthetics.
In numbers
- Trades disclosed
- 93
- Buys
- 1
- Sells
- 12
- Bought
- $100K
- Sold
- $3.3M
- Companies
- 5
- Companies where not an officer
- 1
- First trade
- 19 Nov 2012
- Last trade
- 20 Sep 2026
- Last filed
- 21 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 Sep 2026filed 21 Sep 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code F | $17K1,162 at $14.28 | filing |
| 20 Sep 2026filed 21 Sep 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code F | $17K1,162 at $14.28 | filing |
| 15 May 2026filed 19 May 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | —16,820 at $0.00 | filing |
| 15 May 2026filed 19 May 2026 | NPCE Neuropaceoption or derivative · Medical Devices | SEC FORM 4 Code A | —44,800 at $0.00 | filing |
| 15 May 2026filed 19 May 2026 | NPCE Neuropaceoption or derivative · Medical Devices | SEC FORM 4 Code A | —44,800 at $0.00 | filing |
| 15 May 2026filed 19 May 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | —16,820 at $0.00 | filing |
| 20 Jun 2025filed 24 Jun 2025 | NPCE Neuropaceoption or derivative · Medical Devices | SEC FORM 4 Code A | —87,950 at $0.00 | filing |
| 20 Jun 2025filed 24 Jun 2025 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | —51,850 at $0.00 | filing |
| 12 Mar 2025filed 14 Mar 2025 | STAA STAAR Surgicaloption or derivative · Medical Devices | SEC FORM 4 Code M | —8,153 at $0.00 | filing |
| 12 Mar 2025filed 14 Mar 2025 | STAA STAAR SurgicalMedical Devices | SEC FORM 4 Code M | —8,153 at $0.00 | filing |
| 10 Mar 2025filed 11 Mar 2025 | STAA STAAR Surgicaloption or derivative · Medical Devices | SEC FORM 4 Code M | —4,061 at $0.00 | filing |
| 10 Mar 2025filed 11 Mar 2025 | STAA STAAR SurgicalMedical Devices | SEC FORM 4 Code M | —4,061 at $0.00 | filing |
| 7 Mar 2025filed 11 Mar 2025 | STAA STAAR Surgicaloption or derivative · Medical Devices | SEC FORM 4 Code M | —2,614 at $0.00 | filing |
| 7 Mar 2025filed 11 Mar 2025 | STAA STAAR Surgicaloption or derivative · Medical Devices | SEC FORM 4 Code M | —3,075 at $0.00 | filing |
| 7 Mar 2025filed 11 Mar 2025 | STAA STAAR SurgicalMedical Devices | SEC FORM 4 Code M | —2,614 at $0.00 | filing |
| 7 Mar 2025filed 11 Mar 2025 | STAA STAAR SurgicalMedical Devices | SEC FORM 4 Code M | —3,075 at $0.00 | filing |
| 14 Feb 2025filed 19 Feb 2025 | BRTX BioRestorative Therapiesoption or derivative · Providers & Facilities | SEC FORM 4 Code A | —52,632 at $0.00 | filing |
| 12 Mar 2024filed 14 Mar 2024 | STAA STAAR Surgicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —24,460 at $0.00 | filing |
| 12 Mar 2024filed 14 Mar 2024 | STAA STAAR Surgicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —21,908 at $0.00 | filing |
| 7 Mar 2024filed 11 Mar 2024 | STAA STAAR SurgicalMedical Devices | SEC FORM 4 Code M | —2,614 at $0.00 | filing |
News
Wall Street Zen Upgrades STAAR Surgical (NASDAQ:STAA) to BuySTAA · themarketsdaily.com · 12 Oct 2026
0 headlines in the last 90 days name Patrick F. Williams; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.